Ajax-Loading

Eli Lilly and Company - Other Long Term Assets

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Long-Term-Assets" stands at 6.43 Billion United States Dollars as of 09/30/2025, the highest value since 03/31/2019.

As of the end of Eli Lilly and Company's third quarter, the item "Other Long Term Assets" stands at 6.43 Billion USD. This represents an increase of 3.33 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.59 percent compared to the value the year prior.
The 1 year change in percent is 25.59.
The 3 year change in percent is 41.82.
The 5 year change in percent is 108.95.
The 10 year change in percent is 230.54.

The Serie's long term average value is 3.06 Billion United States Dollars. It's latest available value, on 09/30/2025, is 110.05 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2013, to it's latest available value, on 09/30/2025, is +1,243.44%.
The Serie's change in percent from it's maximum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is -22.59%.

Other Long Term Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Other Long Term Assets486,508,953,600.00
LogoAbbVie Inc - Other Long Term Assets399,570,305,024.00
LogoRoche Holding AG - Other Long Term Assets317,433,206,677.55
LogoAstraZeneca PLC - Other Long Term Assets280,205,508,085.11
LogoNovartis AG - Other Long Term Assets255,096,620,580.91